+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Wearable Injectors Global Market Report 2021: COVID-19 Growth and Change to 2030

  • PDF Icon

    Report

  • May 2021
  • Region: Global
  • The Business Research Company
  • ID: 5321493
Wearable Injectors Global Market Report 2021: COVID-19 Growth and Change to 2030 provides the strategists, marketers and senior management with the critical information they need to assess the global wearable injectors market.







This report focuses on the wearable injectors market which is experiencing strong growth. The report gives a guide to the wearable injectors market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Description:

Where is the largest and fastest growing market for the wearable injectors? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Wearable Injectors market global report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider wearable injectors market, and compares it with other markets.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The wearable injectors market section of the report gives context. It compares the wearable injectors market with other segments of the wearable injectors market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, wearable injectors indicators comparison.

Scope

Markets Covered:

1) By Type: On-Body Injectors; Off-Body Injectors 2) By End-User: Hospitals; Clinics; Homecare setting 3) By Application: Immuno-Oncology; Diabetes; Cardiovascular Diseases; Other

Companies Mentioned: Amgen; Becton, Dickinson and Co.; Enable Injections; Insulet Corporation; Ypsomed

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Frequently Asked Questions about the Global Wearable Injectors Market

What is the estimated value of the Global Wearable Injectors Market?

The Global Wearable Injectors Market was estimated to be valued at $5.71 billion in 2021.

What is the growth rate of the Global Wearable Injectors Market?

The growth rate of the Global Wearable Injectors Market is 16.2%, with an estimated value of $10.39 billion by 2025.

What is the forecasted size of the Global Wearable Injectors Market?

The Global Wearable Injectors Market is estimated to be worth $10.39 billion by 2025.

Who are the key companies in the Global Wearable Injectors Market?

Key companies in the Global Wearable Injectors Market include Amgen, Becton, Dickinson and Co., Enable Injections, Insulet Corporation, Ypsomed, Medtronic, Tandem Diabetes Care and West Pharmaceutical Services.

Table of Contents

1. Executive Summary2. Wearable Injectors Market Characteristics3. Wearable Injectors Market Trends and Strategies4. Impact of COVID-19 on Wearable Injectors
5. Wearable Injectors Market Size and Growth
5.1. Global Wearable Injectors Historic Market, 2015-2020, $ Billion
5.1.1. Drivers of the Market
5.1.2. Restraints on The Market
5.2. Global Wearable Injectors Forecast Market, 2020-2025F, 2030F, $ Billion
5.2.1. Drivers of the Market
5.2.2. Restraints on the Market
6. Wearable Injectors Market Segmentation
6.1. Global Wearable Injectors Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • On-Body Injectors
  • Off-Body Injectors
6.2. Global Wearable Injectors Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Hospitals
  • Clinics
  • Homecare setting
6.3. Global Wearable Injectors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Immuno-Oncology
  • Diabetes
  • Cardiovascular Diseases
  • Other

7. Wearable Injectors Market Regional and Country Analysis
7.1. Global Wearable Injectors Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
7.2. Global Wearable Injectors Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
8. Asia-Pacific Wearable Injectors Market
8.1. Asia-Pacific Wearable Injectors Market Overview
  • Region Information, Impact of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Wearable Injectors Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
8.3. Asia-Pacific Wearable Injectors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
9. China Wearable Injectors Market
9.1. China Wearable Injectors Market Overview
9.2. China Wearable Injectors Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
9.3. China Wearable Injectors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
10. India Wearable Injectors Market
10.1. India Wearable Injectors Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
10.2. India Wearable Injectors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
11. Japan Wearable Injectors Market
11.1. Japan Wearable Injectors Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
11.2. Japan Wearable Injectors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
12. Australia Wearable Injectors Market
12.1. Australia Wearable Injectors Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
12.2. Australia Wearable Injectors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
13. Indonesia Wearable Injectors Market
13.1. Indonesia Wearable Injectors Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
13.2. Indonesia Wearable Injectors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
14. South Korea Wearable Injectors Market
14.1. South Korea Wearable Injectors Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
14.2. South Korea Wearable Injectors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
15. Western Europe Wearable Injectors Market
15.1. Western Europe Wearable Injectors Market Overview
15.2. Western Europe Wearable Injectors Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
15.3. Western Europe Wearable Injectors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
16. UK Wearable Injectors Market
16.1. UK Wearable Injectors Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
16.2. UK Wearable Injectors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
17. Germany Wearable Injectors Market
17.1. Germany Wearable Injectors Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
17.2. Germany Wearable Injectors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
18. France Wearable Injectors Market
18.4. France Wearable Injectors Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
18.5. France Wearable Injectors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
19. Eastern Europe Wearable Injectors Market
19.1. Eastern Europe Wearable Injectors Market Overview
19.2. Eastern Europe Wearable Injectors Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
19.3. Eastern Europe Wearable Injectors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
20. Russia Wearable Injectors Market
20.1. Russia Wearable Injectors Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
20.2. Russia Wearable Injectors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
21. North America Wearable Injectors Market
21.1. North America Wearable Injectors Market Overview
21.2. North America Wearable Injectors Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
21.3. North America Wearable Injectors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
22. USA Wearable Injectors Market
22.1. USA Wearable Injectors Market Overview
22.2. USA Wearable Injectors Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
22.3. USA Wearable Injectors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
23. South America Wearable Injectors Market
23.1. South America Wearable Injectors Market Overview
23.2. South America Wearable Injectors Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
23.3. South America Wearable Injectors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
24. Brazil Wearable Injectors Market
24.1. Brazil Wearable Injectors Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
24.2. Brazil Wearable Injectors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
25. Middle East Wearable Injectors Market
25.1. Middle East Wearable Injectors Market Overview
25.2. Middle East Wearable Injectors Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
25.3. Middle East Wearable Injectors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
26. Africa Wearable Injectors Market
26.1. Africa Wearable Injectors Market Overview
26.2. Africa Wearable Injectors Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
26.3. Africa Wearable Injectors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
27. Wearable Injectors Market Competitive Landscape and Company Profiles
27.1. Wearable Injectors Market Competitive Landscape
27.2. Wearable Injectors Market Company Profiles
27.2.1. Amgen
27.2.1.1. Overview
27.2.1.2. Products and Services
27.2.1.3. Strategy
27.2.1.4. Financial Performance
27.2.2. Becton, Dickinson and Co.
27.2.2.1. Overview
27.2.2.2. Products and Services
27.2.2.3. Strategy
27.2.2.4. Financial Performance
27.2.3. Enable Injections
27.2.3.1. Overview
27.2.3.2. Products and Services
27.2.3.3. Strategy
27.2.3.4. Financial Performance
27.2.4. Insulet Corporation
27.2.4.1. Overview
27.2.4.2. Products and Services
27.2.4.3. Strategy
27.2.4.4. Financial Performance
27.2.5. Ypsomed
27.2.5.1. Overview
27.2.5.2. Products and Services
27.2.5.3. Strategy
27.2.5.4. Financial Performance
28. Key Mergers and Acquisitions in the Wearable Injectors Market29. Wearable Injectors Market Future Outlook and Potential Analysis
30. Appendix
30.1. Abbreviations
30.2. Currencies
30.3. Research Inquiries
30.4. About the Publisher
30.5. Copyright and Disclaimer

Executive Summary

Major players in the wearable injectors market are Amgen, Becton, Dickinson and Co., Enable Injections, Insulet Corporation, Ypsomed, Medtronic, Tandem Diabetes Care, Valeritas, West Pharmaceutical Services,and Sensile Medical AG.

The global wearable injectors market is expected to grow from $5.145 billion in 2020 to $5.709 billion in 2021 at a compound annual growth rate (CAGR) of 11%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $10.393 billion in 2025 at a CAGR of 16%.

The wearable injectors market consists of sales of wearable injectors and related services by entities (organizations, sole traders and partnerships) that manufacture wearable injectors. Wearable injectors are drug delivery devices that adhere to the body while the drug is administered subcutaneously over a preset time duration. Only goods and services traded between entities or sold to end consumers are included.

The focus areas for many companies in the wearable injectors manufacturing market has shifted to increasing mergers and acquisitions to acquire more production capabilities. Large prime manufactures are forming joint ventures or buying small or midsized companies to acquire new capabilities or gain access to new markets. For instance, in April 2020, Zealand Pharma completed its acquisition of Valeritas, Inc., to expand the product portfolios and capabilities of the company. The acquisition is expected to build Zealand Pharma's capabilities and to significantly increase its market share in the market. In April 2018, United Therapeutics acquired SteadyMed Ltd, a USA-based wearable injector manufacturing company to expand the company’s profile.

The wearable injectors market covered in this report is segmented by type into on-body injectors; off-body injectors. It is also segmented by end-user into hospitals; clinics; homecare setting, and by application into immuno-oncology; diabetes; cardiovascular diseases; other.

The high cost associated with wearable injectors is expected to limit the growth of the wearable injectors market. According to Drug Development and Delivery, wearable injectors are single-use systems that are comfortably worn on the body that costs between $20 to $35 per unit, which is high. The high cost associated with wearable injectors has a negative impact on the wearable injectors market growth.

In April 2020, Copenhagen-based Zealand Pharma, a company that develops therapies for gastrointestinal, metabolic diseases, acquired Valeritas a New Jersey-based company that developed wearable insulin delivery devices for a deal amount of $23 million, plus the assumptions of some liabilities. The acquisition is expected to expand the footprint of Zealand Pharma in the US diabetes market. Valeritas, Inc is a medical technology company headquartered in the United States.

The rise in the number of diabetic and chronic diseases patients such as cardiovascular diseases and cancers contributed to the growth of the wearable injectors market. According to the International Diabetes Federation, in 2019, approximately 463 million adults were living with diabetes, and by 2045, it is estimated that around 700 million adults around the world and 1 in 5 adults who are above 65 are expected to suffer from diabetes. The rise in the number of diabetes and chronic diseases patients increased the demand for the treatment of the diseases, thereby driving the wearable injectors market.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Amgen
  • Becton
  • Dickinson and Co.
  • Enable Injections
  • Insulet Corporation
  • Ypsomed
  • Medtronic
  • Tandem Diabetes Care
  • Valeritas
  • West Pharmaceutical Services
  • Sensile Medical AG
  • Gerresheimer
  • Dexcom
  • Consort Medical
  • United Therapeutics
  • Bühler Motor GmbH
  • Debiotech
  • UNILIFE CORPORATION
  • Cellnovo

Methodology

Loading
LOADING...